Heather Payne is a consultant in clinical oncology at University College Hospital and a professor of prostate oncology at University College, London, UK. She trained at St Mary’s Hospital, London, and after qualifying spent time working in general medicine both in London and also in Haiti where conventional medicine was mixed with voodoo practices. Dr Payne returned to London to train as a clinical oncologist, and during this time developed an interest in urological oncology. She now has a busy practice in a teaching hospital where she works within a multidisciplinary team. She is actively involved in clinical research in these therapeutic areas and has pioneered a program of high-dose rate brachytherapy for prostate cancer. Her current research interests include hormone therapy, sensitization of hormones and radiotherapy, predictive indices for bowel toxicity with radiotherapy, proton beam therapy for prostate cancer, chemotherapy, quality of life, and decision-making for men with prostate cancer.
Professor Payne is principal investigator in a number of international multicentre and local studies. She is a trustee of the Prostate Cancer Research Centre, Chair of the British Uro-oncology Group, and Clinical Lead for the National Prostate cancer Audit. She also serves on the Prostate Cancer Charter for Action and the Prostate Cancer Advisory Group for the United Kingdom.